The clinical data of 105 patients with
GH-secreting pituitary adenoma who underwent transsphenoidal adenectomy in our department in 2013 were retrospectively analyzed. The
glucose tolerance status, GH level, and
insulin-like growth factor-1 (IGF-1) level before and after surgery were compared.
RESULTS: Among these 105 patients, the
blood glucose tolerance status included normal
glucose tolerance (NGT) in 47 cases (44.8%), early carbohydrate metabolism disorders (ECMDs) in 26 cases (24.8%), and
diabetes mellitus (DM) in 32 cases (30.5%) before surgery. After the surgery, the fasting
blood glucose (P=0.006, P=0.017) and postprandial
blood glucose (P=0.000, P=0.000) in the ECMDs and DM groups were significantly improved. Also, the random GH (P=0.001, P=0.004, P=0.001), nadir GH (P=0.000, P=0.001, P=0.001), and
IGF-1 (P=0.005, P=0.000, P=0.000) significantly decreased during the follow-up period in NGT, ECMDs and DM groups. Compared with ECMDs and DM groups, the decrease in fasting
blood glucose (P=0.029, P=0.000), postprandial
blood glucose (P=0.003, P=0.000), and serum
IGF-1 (P=0.048, P=0.000) were more significant in DM group.
CONCLUSIONS: